Kim JO - Search Results

1

Atializumab, a humanized anti-aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1) antibody significantly improves nephritis in (NZB/NZW) F1 mice.

Mun CH, Kim JO, Ahn SS, Yoon T, Kim SJ, Ko E, Noh HD, Park YB, Jung HJ, Kim TS, Lee SW, Park SG. Mun CH, et al. Among authors: kim ts, kim jo, kim sj. Biomaterials. 2019 Nov;220:119408. doi: 10.1016/j.biomaterials.2019.119408. Epub 2019 Aug 2. Biomaterials. 2019. PMID: 31394431

2

Serum Aminoacyl-tRNA Synthetase-Interacting Multifunctional Protein-1 Can Predict Severe Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Pilot Monocentric Study.

Ahn SS, Kim JO, Yoon T, Song JJ, Park YB, Lee SW, Park SG. Ahn SS, et al. Among authors: kim jo. Biomed Res Int. 2019 May 20;2019:7508240. doi: 10.1155/2019/7508240. eCollection 2019. Biomed Res Int. 2019. PMID: 31236412 Free PMC article.

3

A fully human anti-c-Kit monoclonal antibody 2G4 inhibits proliferation and degranulation of human mast cells.

Kim KH, Kim JO, Park SG. Kim KH, et al. Among authors: kim jo. Mol Cell Biochem. 2023 Apr;478(4):861-873. doi: 10.1007/s11010-022-04557-3. Epub 2022 Sep 15. Mol Cell Biochem. 2023. PMID: 36107283 Free PMC article.

4

MED28 Over-Expression Shortens the Cell Cycle and Induces Genomic Instability.

Cho JG, Choi JS, Lee JH, Cho MG, Kim HS, Noh HD, Lim KH, Park B, Kim JO, Park SG. Cho JG, et al. Among authors: kim jo, kim hs. Int J Mol Sci. 2019 Apr 9;20(7):1746. doi: 10.3390/ijms20071746. Int J Mol Sci. 2019. PMID: 30970566 Free PMC article.

5

Antibody-immunotoxin Conjugate Using FcBP-mediated Photoconjugation to Treat Cancer.

Kim KH, Park J, Kim JO, Ko HJ, Park SG. Kim KH, et al. Among authors: kim jo. Anticancer Res. 2022 Jul;42(7):3453-3461. doi: 10.21873/anticanres.15832. Anticancer Res. 2022. PMID: 35790260

6

Development and characterization of a fully human antibody targeting SCF/c-kit signaling.

Kim JO, Kim HN, Kim KH, Baek EJ, Park JY, Ha K, Heo DR, Seo MD, Park SG. Kim JO, et al. Among authors: kim hn, kim kh. Int J Biol Macromol. 2020 Sep 15;159:66-78. doi: 10.1016/j.ijbiomac.2020.05.045. Epub 2020 May 11. Int J Biol Macromol. 2020. PMID: 32437800

7

Antibody-Drug Conjugate Targeting c-Kit for the Treatment of Small Cell Lung Cancer.

Kim KH, Kim JO, Park JY, Seo MD, Park SG. Kim KH, et al. Among authors: kim jo. Int J Mol Sci. 2022 Feb 18;23(4):2264. doi: 10.3390/ijms23042264. Int J Mol Sci. 2022. PMID: 35216379 Free PMC article.

8

HAUSP-nucleolin interaction is regulated by p53-Mdm2 complex in response to DNA damage response.

Lim KH, Park JJ, Gu BH, Kim JO, Park SG, Baek KH. Lim KH, et al. Among authors: kim jo. Sci Rep. 2015 Aug 4;5:12793. doi: 10.1038/srep12793. Sci Rep. 2015. PMID: 26238070 Free PMC article.

9

A novel anti-c-Kit antibody-drug conjugate to treat wild-type and activating-mutant c-Kit-positive tumors.

Kim JO, Kim KH, Baek EJ, Park B, So MK, Ko BJ, Ko HJ, Park SG. Kim JO, et al. Among authors: kim kh. Mol Oncol. 2022 Mar;16(6):1290-1308. doi: 10.1002/1878-0261.13084. Epub 2021 Aug 29. Mol Oncol. 2022. PMID: 34407310 Free PMC article.

10

A Fully Human Monoclonal Antibody Targeting cKIT Is a Potent Inhibitor of Pathological Choroidal Neovascularization in Mice.

Seo S, Kim KL, Yeo Y, Kim RI, Jeong H, Kim JO, Song SH, An MJ, Kim JW, Hong HK, Ham MH, Woo SJ, Sung JH, Park SG, Suh W. Seo S, et al. Among authors: kim kl, kim jo, kim ri, kim jw. Pharmaceutics. 2021 Aug 20;13(8):1308. doi: 10.3390/pharmaceutics13081308. Pharmaceutics. 2021. PMID: 34452268 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,250 results

Search Page

Filters